Lexaria Bioscience Arranges Private Placement Financing to Fund New Laboratory

Tickers: XCNQ:LXX, XOTC:LXRP, PINX:LXRPTags: None Kelowna, British Columbia / TheNewswire / October 16, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces it has arranged a non-brokered private placement for…

Lexaria Files New Patent Application for Delivery of Tobacco Derived Products

Tickers: XCNQ:LXX, XOTC:LXRP, PINX:LXRPTags: None Kelowna, British Columbia / TheNewswire / September 28, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces the filing of a new strategic patent application.…

Lexaria Receives Three Patent Grants and Two Notices of Allowance; Provides Patent Portfolio Guidance

Tickers: XCNQ:LXX, XOTC:LXRP, PINX:LXRPTags: None Kelowna, British Columbia / TheNewswire / September 7, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces strategic additions to its patent portfolio. Three new…

Lexaria Bioscience Announces Positive Blood-Brain-Barrier Results

Tickers: XCNQ:LXX, XOTC:LXRP, PINX:LXRPTags: None Lexaria’s technology delivered 195% more nicotine across the blood-brain-barrier conceptually allowing for smaller micro doses in accordance with developing FDA policies. Lexaria’s formulation was 4x faster at reaching its peak level in brain tissue than…

Lexaria Bioscience Announces Further Advancement of Edibles Nicotine Testing Delivery Measured Within Minutes

Tickers: XCNQ:LXX, XOTC:LXRP, PINX:LXRPTags: None – Nicotine, in an edible form, delivered to blood plasma within minutes after dosing. – Statistically significant positive in vivo results (n=40; two groups of 20 animals). – 90.2% greater delivery by the 10-minute mark…

Lexaria Bioscience Announces Further Advancement of Edibles Nicotine Testing Delivery Measured Within Minutes

Tickers: XCNQ:LXX, XOTC:LXRP, PINX:LXRPTags: None Nicotine, in an edible form, delivered to blood plasma within minutes after dosing. Statistically significant positive in vivo results (n=40; two groups of 20 animals). 90.2% greater delivery by the 10-minute mark of the study…